TEL: +86 571 56623320 EMAIL: [email protected]
Product Name IFITM5 Chinese Name Interferon诱导Transmembrane protein5抗体 Alias Bone-restricted interferon-induced transmembrane protein-like protein; BRIL; Fragilis4; Hrmp1; IFITM5; IFM5_HUMAN; Interferon-induced transmembrane protein 5. Research Area Signal transduction Cytoskeleton Extracellular matrix Immunogen Species Rabbit Clonality Polyclonal React Species (predicted: Human, ) Applications WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500,ELISA=1:5000-10000 (Paraffin sections need antigen repair)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.Theoretical molecular weight 14kDa Cellular localization The cell membrane Form Liquid Concentration 1mg/ml immunogen KLH conjugated synthetic peptide derived from human IFITM5: 1-100/132 <Extracellular> Lsotype IgG Purification affinity purified by Protein A Buffer Solution 1M TBS(pH7.4) with 1% BSA, 3% Proclin300 and 50% Glycerol. Storage Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. Attention This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. PubMed PubMed Product Detail IFITM5 is a membrane protein thought to play a role in bone mineralization. This gene is located on chromosome 11 in a cluster of related genes which are induced by interferon, however, this gene has not been shown to be interferon inducible. A similar gene, located in a gene cluster on mouse chromosome 7, is a member of the interferon-inducible fragilis gene family. The mouse gene encodes a transmembrane protein described as participating in germ cell competence. A mutation in the 5' UTR of this gene has been associated with osteogenesis imperfecta type V (PMID: 22863190, 22863195).
Function:
Plays a role in bone mineralization (By similarity).
Subcellular Location:
Cell membrane; Multi-pass membrane protein (By similarity).
DISEASE:
Osteogenesis imperfecta 5 (OI5) [MIM:610967]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI5 patients manifest moderate to severe bone fragility, calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation. Note=The disease is caused by mutations affecting the gene represented in this entry.
Similarity:
Belongs to the CD225/Dispanin family.
SWISS:
A6NNB3
Gene ID:
387733
Database links:Entrez Gene: 387733 Human
Entrez Gene: 73835 Mouse
SwissProt: A6NNB3 Human
SwissProt: O88728 Mouse
Unigene: 443469 Human
Unigene: 389989 Mouse
Ordering & shipping
- Minimum order: 1 unit
- Lead time: varies with order quantity and specifications. Please consult your local distributor or our sales team for confirmation
- Payment: T/T 100% in advance; PayPal; Alibaba Trade Assurance
- Shipping: FedEx / DHL / UPS express; cold-chain packing available on request
- Price: USD, per unit (50ul / 100ul)
| Username | Quantity | bought time |
| Fr*** | 1 | 2026-05-24 |
| Ma*** | 1 | 2026-05-18 |
| Qu*** | 1 | 2026-04-03 |
+86 571 56623320
[email protected]
SUNLONG BIOTECH

Scan Wechat Qrcode
